Zenotech Laboratories logo

Zenotech Laboratories

ZENOTECHLABORATORIESLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹273 Cr
Volatility
Moderate
P/E Ratio
-108.9
EBITDA
₹11.50 Cr
Return on Equity
-1.13%
Debt to Equity
0
Book Value
₹15.59
EPS
₹1.33
52W High
₹56.99
52W Low
₹33.55

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

1
  • Company is almost debt free.

Weaknesses

3
  • Stock is trading at 2.89 times its book value
  • Company has a low return on equity of 3.67% over last 3 years.
  • Debtor days have increased from 55.2 to 73.5 days.

Growth Rate

Revenue Growth
2.91% higher than 3Y
Net Income Growth
-120% lower than 3Y
Cash Flow Change
6.92% higher than 3Y
ROE
-119% lower than 3Y
ROCE
-61.05% higher than 3Y
EBITDA Margin (Avg.)
-29% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
9.26
11.53
10.94
9.11
9.91
9.77
11.24
12.13
9.64
11.23
12.86
9.89
10.62
Expenses
5.59
6.01
5.67
6.33
6.48
7.36
7.37
7.66
7.18
8.94
8.59
9.72
9.76
Operating Profit
3.67
5.52
5.27
2.78
3.43
2.41
3.87
4.47
2.46
2.29
4.27
0.17
0.86
OPM %
39.63%
47.88%
48.17%
30.52%
34.61%
24.67%
34.43%
36.85%
25.52%
20.39%
33.2%
1.72%
8.1%
Other Income
0.2
0.19
0.28
0.33
0.34
1.69
1
0.44
0.59
0.75
0.12
0.65
0.44
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
1.8
1.81
1.74
1.73
1.73
1.75
1.76
1.73
1.77
1.78
1.8
1.76
1.9
PBT
2.07
3.9
3.81
1.38
2.04
2.35
3.11
3.18
1.28
1.26
2.59
-0.94
-0.6
Tax %
29.95%
27.18%
11.55%
51.45%
37.25%
42.55%
45.66%
61.32%
22.66%
165.87%
25.48%
235.11%
-25%
Net Profit
1.44
2.83
3.36
0.66
1.29
1.35
1.69
1.23
0.99
-0.84
1.93
-3.15
-0.46
EPS in Rs
0.24
0.46
0.55
0.11
0.21
0.22
0.28
0.2
0.16
-0.14
0.32
-0.52
-0.08
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
4.08
2.06
2.25
11.14
13.03
26.02
22.45
36.57
42.42
40.83
43.05
43.61
44.6
Expenses
24.14
9.73
12.65
19.01
16.54
17.04
16.07
19.11
21.71
23.56
28.87
34.42
37.01
Operating Profit
-20.06
-7.67
-10.4
-7.87
-3.51
8.98
6.38
17.46
20.71
17.27
14.18
9.19
7.59
OPM %
-491.67%
-372.33%
-462.22%
-70.65%
-26.94%
34.51%
28.42%
47.74%
48.82%
42.3%
32.94%
21.07%
17.02%
Other Income
0.35
0.04
1.91
2.37
4.71
7.54
0.41
0.63
1.08
0.96
3.47
2.11
1.96
Interest
6.65
7.55
7.5
2.45
0.12
0.89
1.55
1.22
0.11
0
0
0
0
Depreciation
4.06
3.96
3.87
3.9
4.2
4.85
6.46
6.97
7.17
7.09
6.96
7.11
7.24
PBT
-30.42
-19.14
-19.86
-11.85
-3.12
10.78
-1.22
9.9
14.51
11.14
10.69
4.19
2.31
Tax %
0%
0%
0%
0%
0%
0%
0%
-123.94%
20.12%
25.49%
47.52%
125.54%
—
Net Profit
-30.41
-19.14
-19.87
-11.85
-3.13
10.78
-1.22
22.18
11.59
8.3
5.61
-1.07
-2.52
EPS in Rs
-4.99
-3.14
-3.26
-1.94
-0.51
1.77
-0.2
3.63
1.9
1.36
0.92
-0.18
-0.42
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
34.43
34.43
34.43
61.03
61.03
61.03
61.03
61.03
61.03
61.03
61.03
61.03
Reserves
-61.68
-80.49
-100
-19.01
-22.13
-11.4
-12.62
9.61
21.24
29.51
35.1
34.09
Borrowings
54.32
54.29
54.28
0
20.24
21.42
20.66
6
0
0
0
0
Other Liabilities
36.64
44.69
62.37
39.72
25.45
14.51
16.78
17.45
18.61
15.66
14.7
16.04
Total Liabilities
63.71
52.92
50.75
81.74
84.59
85.56
85.85
94.09
101
106
111
111
Fixed Assets
52.13
48.17
46.83
44.43
43.11
48.73
74.23
70.91
65.38
65.58
60.87
62.29
CWIP
0
0
0
2.32
16.95
29.08
2.18
0.28
4.98
1.96
3.57
3.6
Investments
0
0
0
0
0
0
0
0
0
0
0
0
Other Assets
11.58
4.75
3.92
34.99
24.53
7.75
9.44
22.9
30.52
38.66
46.39
45.27
Total Assets
63.71
52.92
50.75
81.74
84.59
85.56
85.85
94.09
101
106
111
111
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-7.72
-4.8
1.64
-16.25
-14.04
11.38
5.74
17.67
20.66
11.82
9.54
10.2
Investing
0.34
5.5
-0.69
-2.65
-16.19
-20.79
-4.82
-1.84
-5.82
-21.15
15.21
-6.49
Financing
6.77
-0.83
-0.72
46.83
15.02
-2.7
0.45
-15.87
-6.11
0
0
0
Net Cash Flow
-0.6
-0.13
0.23
27.92
-15.21
-12.11
1.38
-0.04
8.73
-9.33
24.76
3.71
Free Cash Flow
-7.75
-4.81
0.93
-20.07
-32.07
-10.37
0.83
15.73
14.47
7.59
5.62
1.88
CFO/OP
38
76
-15
203
387
130
92
107
106
75
81
105
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
35.78
62.01
0
0
66.11
26.09
61.78
39.22
28.57
29.05
63.16
73.49
Inventory Days
233
305
202
374
294
—
—
—
—
—
—
—
Days Payable
222
816
1,128
2,468
2,089
—
—
—
—
—
—
—
Cash Conversion Cycle
46.05
-449
-926
-2,094
-1,728
26.09
61.78
39.22
28.57
29.05
63.16
73.49
Working Capital Days
-7,875
-17,134
-18,701
-1,219
-1,104
-433
-164
-106
-98.86
-62.93
-27.98
-12.05
ROCE %
-61.54%
-65.67%
—
-61.84%
-5.93%
8.14%
0.47%
15.26%
18.35%
12.94%
9.4%
4.59%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Zenotech Laboratories insights

62 extracted metrics + investor summaries across FY10–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.68.84%Govt.0.98%Others7.36%Public22.81%As ofJun 2026

Documents

Frequently Asked Questions about Zenotech Laboratories

What does Zenotech Laboratories Ltd do?
Incorporated in 1989, Zenotech Laboratories Ltd is in the business of manufacturing biotechnology products[1]
Where is Zenotech Laboratories Ltd (532039) listed?
Zenotech Laboratories Ltd trades as ZENOTECHLABORATORIESLTD on the NSE and under code 532039 on the BSE.
Which sector does Zenotech Laboratories Ltd belong to?
Zenotech Laboratories Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Zenotech Laboratories Ltd?
Zenotech Laboratories Ltd has a market capitalisation of ₹273.39 Cr, which places it in the Small Cap band.
What is the PE ratio of Zenotech Laboratories Ltd?
Zenotech Laboratories Ltd trades at a PE ratio of -108.90, on earnings per share of ₹1.33, against a book value of ₹15.59 per share.
What is the 52-week high and low of Zenotech Laboratories Ltd?
Over the last 52 weeks Zenotech Laboratories Ltd has traded between ₹33.55 and ₹56.99.
What is the Return on Equity (ROE) of Zenotech Laboratories Ltd?
Zenotech Laboratories Ltd reported a return on equity of -1.13%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1989, Zenotech Laboratories Ltd is in the business of manufacturing biotechnology products[1]

Website zenotechlab.com
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/532039.md for Zenotech Laboratories Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List